Avidity Biosciences EBITDA 2019-2024 | RNA
- Avidity Biosciences 2023 EBITDA was -0.245B, a 37.4% increase from 2022.
- Avidity Biosciences 2022 EBITDA was -0.178B, a 51.95% increase from 2021.
- Avidity Biosciences 2021 EBITDA was -0.117B, a 167.08% increase from 2020.
EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.